BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36892600)

  • 1. Five-year follow-up mortality prognostic index for colorectal patients.
    Orive M; Barrio I; Lázaro S; Gonzalez N; Bare M; de Larrea NF; Redondo M; Cortajarena S; Bilbao A; Aguirre U; Sarasqueta C; Quintana JM;
    Int J Colorectal Dis; 2023 Mar; 38(1):64. PubMed ID: 36892600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anxiety, depression, health-related quality of life, and mortality among colorectal patients: 5-year follow-up.
    Orive M; Anton-Ladislao A; Lázaro S; Gonzalez N; Bare M; Fernandez de Larrea N; Redondo M; Bilbao A; Sarasqueta C; Aguirre U; Quintana JM;
    Support Care Cancer; 2022 Oct; 30(10):7943-7954. PubMed ID: 35737143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reference values of EORTC QLQ-C30, EORTC QLQ-BR23, and EQ-5D-5L for women with non-metastatic breast cancer at diagnosis and 2 years after.
    Miret C; Orive M; Sala M; García-Gutiérrez S; Sarasqueta C; Legarreta MJ; Redondo M; Rivero A; Castells X; Quintana JM; Garin O; Ferrer M;
    Qual Life Res; 2023 Apr; 32(4):989-1003. PubMed ID: 36630024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the validity of EQ-5D-5L in people with head & neck cancer: Does a generic quality of life measure perform as well as a disease-specific measure in a patient population?
    Davies A; Waylen A; Leary S; Thomas S; Pring M; Janssen B; Beynon R; Lang S; Schimansky S; Hurley K; Ness A
    Oral Oncol; 2020 Feb; 101():104504. PubMed ID: 31835074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping EORTC-QLQ-C30 and QLQ-CR29 onto EQ-5D-5L in Colorectal Cancer Patients.
    Ameri H; Yousefi M; Yaseri M; Nahvijou A; Arab M; Akbari Sari A
    J Gastrointest Cancer; 2020 Mar; 51(1):196-203. PubMed ID: 30977049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
    Andre T; Amonkar M; Norquist JM; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt CJA; Smith D; Garcia-Carbonero R; Sevilla I; De La Fouchardiere C; Rivera F; Elez E; Diaz LA; Yoshino T; Van Cutsem E; Yang P; Farooqui M; Le DT
    Lancet Oncol; 2021 May; 22(5):665-677. PubMed ID: 33812497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation of long-term cancer survivors and application of statistical cure models: a protocol for an observational follow-up study in patients with colorectal cancer.
    Pértega-Díaz S; Balboa-Barreiro V; Seijo-Bestilleiro R; González-Martín C; Pardeiro-Pértega R; Yáñez-González-Dopeso L; García-Rodríguez T; Seoane-Pillado T
    BMC Public Health; 2020 Nov; 20(1):1738. PubMed ID: 33203431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal cancer health services research study protocol: the CCR-CARESS observational prospective cohort project.
    Quintana JM; Gonzalez N; Anton-Ladislao A; Redondo M; Bare M; Fernandez de Larrea N; Briones E; Escobar A; Sarasqueta C; Garcia-Gutierrez S; Aguirre U;
    BMC Cancer; 2016 Jul; 16():435. PubMed ID: 27391216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of Life After Bladder Cancer: A Cross-sectional Survey of Patient-reported Outcomes.
    Catto JWF; Downing A; Mason S; Wright P; Absolom K; Bottomley S; Hounsome L; Hussain S; Varughese M; Raw C; Kelly P; Glaser AW
    Eur Urol; 2021 May; 79(5):621-632. PubMed ID: 33581875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing health-related quality of life of patients with colorectal cancer using EQ-5D-5L: a cross-sectional study in Heilongjiang of China.
    Huang W; Yang J; Liu Y; Liu C; Zhang X; Fu W; Shi L; Liu G
    BMJ Open; 2018 Dec; 8(12):e022711. PubMed ID: 30530472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term health-related quality of life following colorectal cancer surgery: patient-reported outcomes in a remote follow-up population.
    Malcolm FL; Adiamah A; Banerjea A; Whitehead D; Gupta A; West J; Humes DJ;
    Colorectal Dis; 2021 Jan; 23(1):213-225. PubMed ID: 33021013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The EORTC QLQ-C30 Summary Score as Prognostic Factor for Survival of Patients with Cancer in the "Real-World": Results from the Population-Based PROFILES Registry.
    Husson O; de Rooij BH; Kieffer J; Oerlemans S; Mols F; Aaronson NK; van der Graaf WTA; van de Poll-Franse LV
    Oncologist; 2020 Apr; 25(4):e722-e732. PubMed ID: 32297435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping EORTC QLQ-C30 and FACT-G onto EQ-5D-5L index for patients with cancer.
    Hagiwara Y; Shiroiwa T; Taira N; Kawahara T; Konomura K; Noto S; Fukuda T; Shimozuma K
    Health Qual Life Outcomes; 2020 Nov; 18(1):354. PubMed ID: 33143687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring the Time to Deterioration for Health-Related Quality of Life in Patients With Metastatic Breast Cancer Using a Web-Based Monitoring Application: Longitudinal Cohort Study.
    Brusniak K; Feisst M; Sebesteny L; Hartkopf A; Graf J; Engler T; Schneeweiss A; Wallwiener M; Deutsch TM
    JMIR Cancer; 2021 Oct; 7(4):e25776. PubMed ID: 34636732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-related quality of life in long-term survivors of colorectal cancer and its association with all-cause mortality: a German cohort study.
    Ratjen I; Schafmayer C; Enderle J; di Giuseppe R; Waniek S; Koch M; Burmeister G; Nöthlings U; Hampe J; Schlesinger S; Lieb W
    BMC Cancer; 2018 Nov; 18(1):1156. PubMed ID: 30466408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic values of EORTC QLQ-C30 and QLQ-HCC18 index-scores in patients with hepatocellular carcinoma - clinical application of health-related quality-of-life data.
    Li L; Mo FK; Chan SL; Hui EP; Tang NS; Koh J; Leung LK; Poon AN; Hui J; Chu CM; Lee KF; Ma BB; Lai PB; Chan AT; Yu SC; Yeo W
    BMC Cancer; 2017 Jan; 17(1):8. PubMed ID: 28052758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping EORTC-QLQ-C30 to EQ-5D-3L in patients with colorectal cancer.
    Marriott ER; van Hazel G; Gibbs P; Hatswell AJ
    J Med Econ; 2017 Feb; 20(2):193-199. PubMed ID: 27676291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma.
    Proskorovsky I; Lewis P; Williams CD; Jordan K; Kyriakou C; Ishak J; Davies FE
    Health Qual Life Outcomes; 2014 Mar; 12():35. PubMed ID: 24618388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Which Questionnaire Should Be Used to Measure Quality-of-Life Utilities in Patients with Acute Leukemia? An Evaluation of the Validity and Interpretability of the EQ-5D-5L and Preference-Based Questionnaires Derived from the EORTC QLQ-C30.
    van Dongen-Leunis A; Redekop WK; Uyl-de Groot CA
    Value Health; 2016; 19(6):834-843. PubMed ID: 27712712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health-related quality of life of long-term patients receiving opioid agonist therapy: a nested prospective cohort study in Norway.
    Aas CF; Vold JH; Skurtveit S; Lim AG; Ruths S; Islam K; Askildsen JE; Løberg EM; Fadnes LT; Johansson KA;
    Subst Abuse Treat Prev Policy; 2020 Sep; 15(1):68. PubMed ID: 32883319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.